STOCK TITAN

Aspire Biopharma to rename as Aspire-Lakewood

Aspire Biopharma is rebranding as Aspire-Lakewood Holdings to reflect a holding company structure centered on Dura Control Systems Corp.

(Very High)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Aspire Biopharma Holdings, Inc. (Nasdaq: ASBP) reported that it has changed its corporate name to Aspire-Lakewood Holdings, Inc., effective upon filing a Certificate of Amendment to its Certificate of Incorporation with the Delaware Secretary of State. The company’s common stock will continue to trade on The Nasdaq Capital Market under the same ticker symbol, and existing stock certificates remain valid.

The name change, approved by the board and stockholders under Section 242 of the Delaware General Corporation Law, is positioned as aligning the company’s holding company structure with its expanded focus following the acquisition of Dura Control Systems Corp. (DCSC), a designer and manufacturer of engineered automotive and industrial control systems. The change does not alter stockholder rights or require any action by stockholders.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Par value per share $0.0001 per share Par value of common stock listed for trading under symbol ASBP
Patents held by DCSC Over 310 patents Dura Control Systems Corp. intellectual property portfolio backing its product offerings
Manufacturing facilities 11 facilities Number of manufacturing facilities operated globally by Dura Control Systems Corp.
Lakewood & Company founding year 2005 Year Lakewood & Company, LLC was founded as a multi-stage investment firm
Certificate of Amendment regulatory
"effective upon the filing of a Certificate of Amendment to the Company’s Certificate of Incorporation"
A certificate of amendment is an official filing that updates a company’s founding documents—its legal “rulebook” that sets share structure, voting rules, name and basic purpose. Think of it like changing the blueprint of a building: small changes are paperwork, big ones can alter who owns how much and who controls decisions. Investors watch these filings because they can affect share counts, voting power, dilution and company value.
General Corporation Law of the State of Delaware regulatory
"in accordance with Section 242 of the General Corporation Law of the State of Delaware"
A state-level statutory framework that acts like a widely used rulebook for how corporations are formed, governed, and dissolved in Delaware. It sets binding rules on directors’ powers, shareholder rights, mergers, and fiduciary duties, and matters to investors because it creates predictable legal outcomes and clear governance standards—like playing a game with well-known rules—affecting control, takeover risk, and the protection of shareholder interests.
holding company structure financial
"Adopting a holding company structure better aligns our corporate architecture"
A holding company structure is an arrangement where one parent company owns controlling stakes in multiple separate businesses (subsidiaries) while the parent itself usually handles ownership, financing and strategy rather than day‑to‑day operations. For investors, this matters because it can isolate risk, concentrate cash flows or liabilities in particular units and make it easier to sell or reorganize parts of the enterprise—like a landlord owning several rental properties rather than managing each apartment directly—so you must assess both the parent’s balance sheet and the health of its subsidiaries.
tier one automotive supplier technical
"serves as a tier one automotive supplier to major OEMs and other industrial firms"
powertrain agnostic technical
"DCSC maintains a strong powertrain agnostic product portfolio that includes mechatronic actuators"
forward-looking statements regulatory
"Certain statements made in this communication are “forward-looking statements” within the meaning"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

FAQ

What corporate change did ASBP announce on September 8, 2026?

The company announced a corporate name change from Aspire Biopharma Holdings, Inc. to Aspire-Lakewood Holdings, Inc., effective upon filing a Certificate of Amendment with the Delaware Secretary of State, with no change to the existing rights of stockholders.

Does the ASBP ticker change after the Aspire-Lakewood name change?

No. The company states that its ticker symbol will remain ASBP and that its common stock will continue to trade on The Nasdaq Capital Market. The name change does not affect the listing or trading of its common stock.

Do ASBP stockholders need to take any action due to the name change?

No action is required. The company states that stockholders holding shares in book-entry or through a bank or broker are not required to act, and existing stock certificates reflecting the prior name will continue to be valid after the name change.

Why is Aspire Biopharma changing its name to Aspire-Lakewood Holdings?

Management explains that the name change follows the acquisition of Dura Control Systems Corp. and the company’s evolution into a high-volume, diversified enterprise. Adopting a holding company structure is described as better aligning with this expanded business focus.

What business does Aspire-Lakewood’s subsidiary Dura Control Systems Corp. operate?

Dura Control Systems Corp. is described as a designer and manufacturer of automotive and industrial control systems, offering mechatronic actuators, human machine interfaces, industrial cables, and cable control systems, with a powertrain agnostic portfolio supported by over 310 patents and 11 manufacturing facilities globally.

How was the Aspire-Lakewood name change approved under Delaware law?

The company states that the name change was approved by its board of directors and stockholders in accordance with Section 242 of the General Corporation Law of the State of Delaware, and became effective upon filing a Certificate of Amendment.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false 0001847345 0001847345 2026-09-08 2026-09-08 0001847345 ASBP:CommonStockParValue0.0001PerShareMember 2026-09-08 2026-09-08 0001847345 ASBP:WarrantsEachExercisableForOneShareOfCommonStockMember 2026-09-08 2026-09-08 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 OR 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): September 8, 2026

 

Aspire Biopharma Holdings, Inc.

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware   001-41293   33-3467744

(State or other jurisdiction

of incorporation)

 

(Commission

File No.)

 

(I.R.S. Employer

Identification No.)

 

23150 Fashion Drive

Estero, FL 33928

(Address of Principal Executive Offices)

 

(415) 592-7399

(Registrant’s Telephone Number)

 

PowerUp Acquisition Corp.

188 Grand Street, Unit #195

New York, NY 10013

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common stock, par value $0.0001 per share   ASBP   The Nasdaq Stock Market LLC
Warrants, each exercisable for one share of common stock   ASBPW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 
 

 

Item 7.01 Regulation FD Disclosure

 

On September 8, 2026, the Company issued a press release. A copy of the press release is furnished hereto as Exhibit 99.1 and incorporated herein by reference.

 

Item 9.01. Financial Statements and Exhibits.

 

Exhibit No.   Description
99.1   Press Release dated September 8, 2026
104   Cover Page Interactive Data File (embedded with the Inline XBRL document).

 

 
 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ASPIRE BIOPHARMA HOLDINGS, INC.
     
  By: /s/ Kraig Higginson
    Kraig Higginson
    Chief Executive Officer
     
Date: September 8, 2026    

 

 

 

 

Exhibit 99.1

 

ASPIRE BIOPHARMA HOLDINGS, INC. ANNOUNCES CORPORATE NAME CHANGE TO ASPIRE-LAKEWOOD HOLDINGS, INC.

 

ESTERO, FL / September 8, 2026 Aspire Biopharma Holdings, Inc. (Nasdaq: ASBP) (“Aspire” or the “Company”), today announced that it has changed its corporate name from “Aspire Biopharma Holdings, Inc.” to “Aspire-Lakewood Holdings, Inc.” The name change is effective upon the filing of a Certificate of Amendment to the Company’s Certificate of Incorporation with the Secretary of State of the State of Delaware. The Company’s ticker symbol, “ASBP”, will remain unchanged.

 

Kraig Higginson, Chief Executive Officer of Aspire-Lakewood Holdings, commented, “Transitioning our corporate identity to Aspire-Lakewood Holdings, Inc. marks a pivotal milestone in our evolution. Following our recent acquisition of Dura Control Systems Corp., Aspire has successfully scaled into a high-volume, diversified enterprise. Adopting a holding company structure better aligns our corporate architecture with this expanded business focus.”

 

The name change was approved by the Company’s board of directors (the “Board”) and stockholders in accordance with Section 242 of the General Corporation Law of the State of Delaware. The name change reflects the Company’s evolving business strategy and operations.

 

The Company’s common stock will continue to trade on The Nasdaq Capital Market. In connection with the name change, the Company’s trading symbol on Nasdaq will remain the same (“ASPB”). Stockholders holding shares in book-entry form or through a bank, broker, or other nominee are not required to take any action in connection with the name change.

 

The name change does not affect the rights of the Company’s stockholders. The Company’s shares of common stock will continue to be listed and traded on Nasdaq and will not be affected by the name change. No action is required by current stockholders with respect to the name change, and stock certificates reflecting the prior corporate name will continue to be valid.

 

About Aspire-Lakewood Holdings, Inc.

 

Aspire-Lakewoood Holdings, Inc.’s subsidiary, Dura Control Systems Corp. (DCSC), is a leading designer and manufacturer of highly engineered automotive and industrial control systems that combine mechanical engineering, electronics and computer science to provide intelligent, automated systems for vehicle electrification, safety, lightweighting, and sustainability. DCSC maintains a strong powertrain agnostic product portfolio that includes mechatronic actuators, human machine interfaces, industrial cables, and cable control systems backed by over 310 patents. The Company operates 11 manufacturing facilities globally and serves as a tier one automotive supplier to major OEMs and other industrial firms.

 

About Lakewood & Company, LLC

 

Lakewood & Company, LLC is a multi-stage investment firm founded in 2005 to complete global private equity investments in businesses that operate in the Industrial and Business Services sectors. Lakewood’s partners provide a track record of success as investors and operating executives and as a result provide an operational focus to invest in opportunities that have a hands-on, collaborative partnership with management. Lakewood professionals represent decades of investment and operating experience from diverse backgrounds in industrials and business services and sources capital to complete its investments on a deal-by-deal basis with investors from family offices, UHNWI, and institutions.

 

For more information, please visit www.aspirebiolabs.com

 

 

 

 

Aspire-Lakewood Holdings, Inc.

 

Contact

 

PCG Advisory

Kevin McGrath

+1-646-418-7002

kevin@pcgadvisory.com

 

Safe Harbor Statement

 

Certain statements made in this communication are “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may generally be identified by the use of words such as “estimate,” “projects,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “would,” “should,” “future,” “propose,” “potential,” “target,” “goal,” “objective,” “outlook” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding the financial position, business strategy and the plans and objectives of management for future operations. These statements are based on various assumptions, whether or not identified in this communication, and on the current expectations of Aspire-Lakewood’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by any investor as a guarantee, an assurance, a prediction or a definitive statement of fact or probability. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the control of the parties, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

 

 

 

Filing Exhibits & Attachments

5 documents

Keep reading